Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06511011
PHASE2

Chinese Medicine in Treating Insomnia

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This is a randomized, double-blinded, placebo-controlled clinical trial. Eligible participants will randomized into either treatment group (CM granules) or placebo group (placebo granules) for 6 weeks, followed by a post-treatment visit at week 9. The primary outcome is the change in Pittsburgh Sleep Quality Index (PSQI) at week 6.

Official title: Efficacy and Safety of Modified Suan ZaoRen Tang-TianWang BuXin Dan in the Treatment of Chronic Insomnia: A Randomized, Double-blinded, Placebo-controlled Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

76

Start Date

2024-09

Completion Date

2026-08

Last Updated

2024-07-25

Healthy Volunteers

No

Interventions

DRUG

Modified Suan ZaoRen Tang-TianWang BuXin Dan

Chinese medicine granules for 6 weeks

DRUG

Placebo

Placebo granules for 6 weeks